- Home
- WTFC vs CORT Comparison
WTFC vs CORT Comparison
Compare WTFC & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WTFC
- CORT
- Stock Information
- Founded
- WTFC 1991
- CORT 1998
- Country
- WTFC United States
- CORT United States
- Employees
- WTFC N/A
- CORT N/A
- Industry
- WTFC Major Banks
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- WTFC Finance
- CORT Health Care
- Exchange
- WTFC Nasdaq
- CORT Nasdaq
- Market Cap
- WTFC 7.8B
- CORT 7.1B
- IPO Year
- WTFC N/A
- CORT N/A
- Fundamental
- Price
- WTFC $122.16
- CORT $70.59
- Analyst Decision
- WTFC Strong Buy
- CORT Strong Buy
- Analyst Count
- WTFC 15
- CORT 4
- Target Price
- WTFC $131.67
- CORT $142.00
- AVG Volume (30 Days)
- WTFC 428.9K
- CORT 1.4M
- Earning Date
- WTFC 04-21-2025
- CORT 05-05-2025
- Dividend Yield
- WTFC 1.64%
- CORT N/A
- EPS Growth
- WTFC 4.71
- CORT 8.36
- EPS
- WTFC 10.13
- CORT 1.14
- Revenue
- WTFC $2,383,650,000.00
- CORT $685,446,000.00
- Revenue This Year
- WTFC $15.72
- CORT $35.85
- Revenue Next Year
- WTFC $5.34
- CORT $35.22
- P/E Ratio
- WTFC $12.06
- CORT $61.82
- Revenue Growth
- WTFC 8.51
- CORT 30.93
- 52 Week Low
- WTFC $89.10
- CORT $25.35
- 52 Week High
- WTFC $142.04
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- WTFC 67.78
- CORT 50.86
- Support Level
- WTFC $113.39
- CORT $69.33
- Resistance Level
- WTFC $123.46
- CORT $73.36
- Average True Range (ATR)
- WTFC 2.63
- CORT 3.66
- MACD
- WTFC 1.40
- CORT -0.20
- Stochastic Oscillator
- WTFC 92.17
- CORT 39.15
About WTFC Wintrust Financial Corporation
Wintrust Financial Corp is a financial holding company that provides community-oriented, personal, and commercial banking services to customers generally located in the Chicago metropolitan area, southern Wisconsin, northwest Indiana, and western Michigan. The company provides specialty finance services, including financing for the payment of property and casualty insurance premiums and life insurance premiums, and wealth management services to customers in its market area. The company's operations consist of three primary segments: community banking, specialty finance, and wealth management. The company generates the majority of its revenue from the community banking segment.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.